Table 5. . Modified response evaluation criteria in solid tumors-response on 1-month follow-up per nodule.
| Response, n (%) | TACE 1 (34) | TACE 2 (13) | TACE 3 (2) | TACE global† (39) |
|---|---|---|---|---|
| CR | 14/34 (41.2) | 6/13 (46.2) | 1/2 (50) | 19/39 (48.7) |
| PR | 10/34 (29.4) | 4/13 (30.8) | 0/2 (0) | 14/39 (25.6) |
| SD | 10/34 (29.4) | 3/13 (23.1) | 1/2 (50) | 14/39 (25.6) |
| PD | 0/34 (0) | 0/13 (0) | 0/2 (0) | 0/39 (0) |
†
The best response by nodule was reported in TACE global.
CR: Complete response; mRECIST: Modified response evaluation criteria in solid tumors; PD: Progressive disease; PR: Partial response; SD: Stable disease; TACE: Transarterial chemoembolization.